ENDRA LIFE SCIENCES INC. Proceeds from Common Stock Issued
ENDRA LIFE SCIENCES INC. (NDRA) reported Proceeds from Common Stock Issued of $357.68 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. proceeds from issuance of common stock for the quarter ending 2026-06-30 was $93.94K, a 89.04% decline year-over-year.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of common stock for the quarter ending 2026-03-31 was $263.75K, a 80.89% increase year-over-year.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $65.56K, a 98.45% decline year-over-year.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $149.47K.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of common stock for fiscal 2025 was $1.22M, a 77.31% decline from fiscal 2024.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of common stock for fiscal 2024 was $5.37M, a 17.20% decline from fiscal 2023.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of common stock for fiscal 2023 was $6.48M, a 22.81% decline from fiscal 2022.
- ENDRA LIFE SCIENCES INC. proceeds from issuance of common stock for fiscal 2022 was $8.40M, a 20.88% decline from fiscal 2021.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $357.68K 10-Q · filed 2026-08-14 | $423.24K derived: sum of 3 quarters · filed 2026-08-14 | $572.71K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $263.75K 10-Q · filed 2026-05-15 | $329.30K derived: sum of 2 quarters · filed 2026-05-15 | $478.77K derived: sum of 3 quarters · filed 2026-05-15 | $1.34M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $65.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $215.02K derived: sum of 2 quarters · filed 2026-03-31 | $1.07M derived: sum of 3 quarters · filed 2026-08-14 | $1.22M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $149.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.01M derived: sum of 2 quarters · filed 2026-08-14 | $1.15M 10-Q · filed 2025-11-14 | $5.37M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $857.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.00M 10-Q · filed 2026-08-14 | $5.22M derived: sum of 3 quarters · filed 2026-08-14 | $5.22M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $145.80K 10-Q · filed 2026-05-15 | $4.37M derived: sum of 2 quarters · filed 2026-05-15 | $4.37M derived: sum of 3 quarters · filed 2026-05-15 | $5.09M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $4.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.22M derived: sum of 2 quarters · filed 2026-03-31 | $4.95M derived: sum of 3 quarters · filed 2026-03-31 | $5.37M 10-K · filed 2026-03-31 | $1.15M 10-K · filed 2025-03-31 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $728.50K derived: sum of 2 quarters · filed 2025-11-14 | $1.15M 10-Q · filed 2025-11-14 | $1.81M derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $728.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.15M 10-Q · filed 2025-08-14 | $1.81M derived: sum of 3 quarters · filed 2025-08-14 | $2.92M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-06-04 | $7.34M 10-K · filed 2026-03-31 | |||||
| 2024-03-31 | $419.97K 10-Q · filed 2025-05-15 | $1.08M derived: sum of 2 quarters · filed 2025-05-15 | $2.19M derived: sum of 3 quarters · filed 2025-05-15 | $6.90M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $656.81K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-04-07 | $1.77M derived: sum of 2 quarters · filed 2025-04-07 | $6.48M derived: sum of 3 quarters · filed 2025-04-07 | $6.48M 10-K/A · filed 2025-04-07 | ||
| 2023-09-30 | $1.11M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-11-21 | $5.83M derived: sum of 2 quarters · filed 2024-11-21 | $5.83M 10-Q/A · filed 2024-11-21 | $5.83M derived: sum of 4 quarters · filed 2024-11-21 | ||
| 2023-06-30 | $4.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $4.71M 10-Q · filed 2024-08-14 | $4.71M derived: sum of 3 quarters · filed 2024-08-14 | $4.71M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2024-05-14 | $0.00 derived: sum of 3 quarters · filed 2024-05-14 | $7.55M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $7.55M derived: sum of 3 quarters · filed 2024-03-28 | $8.40M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $7.55M derived: sum of 2 quarters · filed 2023-11-14 | $8.40M 10-Q · filed 2023-11-14 | $8.72M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $7.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $8.40M 10-Q · filed 2023-08-14 | $8.72M derived: sum of 3 quarters · filed 2023-08-14 | $9.22M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $854.05K 10-Q · filed 2023-05-15 | $1.18M derived: sum of 2 quarters · filed 2023-05-15 | $1.67M derived: sum of 3 quarters · filed 2023-05-15 | $1.67M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $321.08K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $817.68K derived: sum of 2 quarters · filed 2023-03-16 | $817.68K derived: sum of 3 quarters · filed 2023-03-16 | $10.62M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $496.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $496.61K derived: sum of 2 quarters · filed 2022-11-14 | $10.29M 10-Q · filed 2022-11-14 | $15.75M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $9.80M 10-Q · filed 2022-08-15 | $15.26M derived: sum of 3 quarters · filed 2022-08-15 | $15.79M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $9.80M 10-Q · filed 2022-05-12 | $15.26M derived: sum of 2 quarters · filed 2022-05-12 | $15.79M derived: sum of 3 quarters · filed 2022-05-12 | $16.58M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $5.99M derived: sum of 2 quarters · filed 2022-03-30 | $6.78M derived: sum of 3 quarters · filed 2022-03-30 | $6.78M 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $530.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.32M derived: sum of 2 quarters · filed 2021-11-15 | $1.32M 10-Q · filed 2021-11-15 | $1.45M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $791.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $791.47K 10-Q · filed 2021-08-12 | $916.47K derived: sum of 3 quarters · filed 2021-08-12 | $916.47K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | $125.00K derived: sum of 2 quarters · filed 2021-05-17 | $125.00K derived: sum of 3 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $125.00K derived: sum of 2 quarters · filed 2021-03-25 | $125.00K 10-K · filed 2021-03-25 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 | |||||
| 2018-12-31 | $7.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $7.74M derived: sum of 2 quarters · filed 2020-03-26 | $7.74M 10-K · filed 2020-03-26 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $0.00 10-Q · filed 2018-11-05 | ||||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-13 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $0.00 derived: sum of 2 quarters · filed 2019-03-11 | $8.59M derived: sum of 3 quarters · filed 2019-03-11 | $8.59M 10-K · filed 2019-03-11 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $8.59M derived: sum of 2 quarters · filed 2018-11-05 | $8.59M 10-Q · filed 2018-11-05 | $8.59M derived: sum of 4 quarters · filed 2018-11-05 | ||
| 2017-06-30 | $8.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $8.59M 10-Q · filed 2018-08-13 | $8.59M derived: sum of 3 quarters · filed 2018-08-13 | $8.59M derived: sum of 4 quarters · filed 2018-08-13 | ||
| 2017-03-31 | $0.00 10-Q · filed 2017-06-21 | $0.00 derived: sum of 2 quarters · filed 2018-03-20 | $0.00 derived: sum of 3 quarters · filed 2018-03-20 | $0.00 derived: sum of 4 quarters · filed 2018-03-20 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $0.00 derived: sum of 2 quarters · filed 2018-03-20 | $0.00 derived: sum of 3 quarters · filed 2018-03-20 | $5.00K 10-K · filed 2018-03-20 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $5.00K 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $5.00K 10-Q · filed 2017-08-07 | ||||
| 2016-03-31 | $5.00K 10-Q · filed 2017-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |